Benjamin F. Edwards & Company Inc. cut its stake in shares of Clorox Company (The) (NYSE:CLX) by 4.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,052 shares of the company’s stock after selling 477 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Clorox Company (The) were worth $1,339,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in CLX. BlackRock Inc. increased its stake in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares during the period. Parnassus Investments CA acquired a new stake in shares of Clorox Company (The) during the first quarter valued at about $434,255,000. Vanguard Group Inc. increased its stake in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares during the period. Morgan Stanley increased its stake in shares of Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock valued at $134,342,000 after buying an additional 241,210 shares during the period. Finally, WINTON GROUP Ltd increased its stake in shares of Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock valued at $28,566,000 after buying an additional 201,737 shares during the period. 69.83% of the stock is currently owned by hedge funds and other institutional investors.
Clorox Company (NYSE:CLX) traded up 0.41% on Friday, reaching $137.73. The company’s stock had a trading volume of 734,445 shares. The company has a market cap of $17.78 billion, a P/E ratio of 25.82 and a beta of 0.40. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The firm’s 50-day moving average price is $133.42 and its 200 day moving average price is $134.00.
Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.30 EPS. Equities analysts anticipate that Clorox Company will post $5.67 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://stocknewstimes.com/2017/08/18/benjamin-f-edwards-company-inc-has-1-34-million-stake-in-clorox-company-the-nyseclx-updated.html.
A number of research analysts recently issued reports on the company. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price objective for the company in a report on Monday, April 24th. Royal Bank Of Canada set a $115.00 price objective on Clorox Company (The) and gave the stock a “hold” rating in a report on Monday, April 24th. Jefferies Group LLC set a $138.00 price objective on Clorox Company (The) and gave the stock a “hold” rating in a report on Wednesday, May 3rd. BMO Capital Markets reiterated a “buy” rating and set a $136.00 price objective on shares of Clorox Company (The) in a report on Thursday, May 4th. Finally, UBS AG reiterated a “sell” rating and set a $121.00 price objective (up from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $129.05.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
